The $680m deal includes UCB's brands Keppra, Vimpat, Neupro, Zyrtec, Xyzal, and its Zhuhai manufacturing site, and was made in partnership with Mubadala Investment Co.
China is shifting towards manufacturing abroad as opposed to natural resources; on the other hand, Chinese overseas lending has weakened due to domestic economic concerns.
Outstanding mortgage rates for individual borrowers will be cut by 0.5%, potentially helping around 50 million households, while the reserve requirement ratio (RRR) for most banks will also be cut by 0.5%.
FA spoke to the CEO of Dubai-based private equity player Fajr Capital, on China’s Belt and Road Initiative, the importance of the Rmb, fast-growing sectors, and how Chinese firms can expand in the Middle East.
Hong Kong-based Yang has previous CFO experience at major Chinese e-commerce firms, and has also worked in the technology, media and telecommunications' investment banking team at Citi.
Greater liberalisation and new access schemes aim to help offshore investors tap China's vast bond market, plus give them tools to better manage risk and liquidity. How can fixed income portfolios capitalise on these initiatives?